Hu, X.; Wang, X.; Yu, X.; Ni, L.; Gao, C.; Pan, X.; Ren, H.; Xu, J.; Ma, J.
The Role of Renal PLA2R Staining Combined with Serum PLA2R Antibody in Membranous Nephropathy Risk Stratification. J. Clin. Med. 2024, 13, 68.
https://doi.org/10.3390/jcm13010068
AMA Style
Hu X, Wang X, Yu X, Ni L, Gao C, Pan X, Ren H, Xu J, Ma J.
The Role of Renal PLA2R Staining Combined with Serum PLA2R Antibody in Membranous Nephropathy Risk Stratification. Journal of Clinical Medicine. 2024; 13(1):68.
https://doi.org/10.3390/jcm13010068
Chicago/Turabian Style
Hu, Xiaofan, Xinlu Wang, Xialian Yu, Liyan Ni, Chenni Gao, Xiaoxia Pan, Hong Ren, Jing Xu, and Jun Ma.
2024. "The Role of Renal PLA2R Staining Combined with Serum PLA2R Antibody in Membranous Nephropathy Risk Stratification" Journal of Clinical Medicine 13, no. 1: 68.
https://doi.org/10.3390/jcm13010068
APA Style
Hu, X., Wang, X., Yu, X., Ni, L., Gao, C., Pan, X., Ren, H., Xu, J., & Ma, J.
(2024). The Role of Renal PLA2R Staining Combined with Serum PLA2R Antibody in Membranous Nephropathy Risk Stratification. Journal of Clinical Medicine, 13(1), 68.
https://doi.org/10.3390/jcm13010068
